Published in
Elsevier, Annals of Oncology, 9(31), p. 1178-1185, 2020
DOI: 10.1016/j.annonc.2020.04.473
Links
Tools
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
Journal article published in 2020 by
C. Lu,
A. Terbuch,
D. Dolling,
J. Yu,
H. Wang,
Y. Chen,
J. Fountain,
C. Bertan,
A. Sharp,
S. Carreira,
W. B. Isaacs,
E. S. Antonarakis,
J. S. De Bono 
,
J. Luo
,
J. Luo
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 